GlycoDisplay Aps develops novel biopharmaceuticals by modifying sugars. The proprietary technology applies targeted cell engineering to display different glycans on cells and proteins. GlycoDisplay is a spin-out from University of Copenhagen, Center for Glycomics, which is world leading within the field of glyco-engineering and glycomics.
The Glycodisplay business model focuses on specific drug programs where glyco-optimized leads are identified either internally or in close collaboration with pharmaceutical companies.
Company Details
- Founded
- 2016
- Address
- Blegdamsvej 3b,, Copenhagen,denmark Dk2200,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- glycodisplay.com
- Keywords
- Biopharmaceuticals, Glycoengineering, Cell Technologies, Protein Research, Gene editing, Glycomics, Glycoanalysis, Molecular Biology, Production Cell Line Development.
- HQ
- Copenhagen, Denmark
Glycodisplay Aps Questions
Glycodisplay Aps's website is glycodisplay.com
Glycodisplay Aps's LinkedIn profile is https://dk.linkedin.com/company/glycodisplay-aps
Glycodisplay Aps's industry is
Biotechnology Research
Glycodisplay Aps's categories are Biotechnology Research
Glycodisplay Aps's founding year is 2016
